VeriMompalmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine é seguro durante a gravidez?
No harmonised CLP classification or SCCS/CIR reproductive safety restriction was found for this ingredient. No peer‑reviewed reproductive or developmental toxicity data were identified. As a large palmitoyl‑peptide used topically, dermal absorption is expected to be negligible, and there is no structural or mechanistic evidence of reproductive toxicity. Sources consulted include PubChem, CosIng, PubMed (no reproductive studies), ECHA (no Annex VI harmonised classification), and EWG.
Pregnancy-safe products containing palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine
Related ingredients
Frequently asked questions
- palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine é seguro durante a gravidez?
- No harmonised CLP classification or SCCS/CIR reproductive safety restriction was found for this ingredient. No peer‑reviewed reproductive or developmental toxicity data were identified. As a large palmitoyl‑peptide used topically, dermal absorption is expected to be negligible, and there is no structural or mechanistic evidence of reproductive toxicity. Sources consulted include PubChem, CosIng, PubMed (no reproductive studies), ECHA (no Annex VI harmonised classification), and EWG.
- palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine é seguro durante a amamentação?
- No data indicating transfer into breast milk or lactation-related toxicity. Given the peptide's size/polarity and expected negligible systemic absorption after topical use, risk of exposure to breastfed infants is unlikely. No regulatory flags (ECHA Annex VI, SCCS, CIR) or peer‑reviewed evidence were found.
- palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine é seguro para a pele do bebê?
- No infant‑specific reproductive or toxicology data located. Adult dermal absorption is expected negligible; however, infant skin has a higher surface‑area‑to‑weight ratio and immature barrier, so exposure score is increased by +1 for 0–3 yr. There is still no mechanistic or hazard evidence suggesting reproductive or developmental toxicity for infants.
- Como o VeriMom pontua palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine?
- O VeriMom pontua palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine em 100/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine na gravidez?
- Veja nossa lista curada de alternativas seguras a palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.